CD8A and hepatocellular carcinoma: Not surprisingly, followed by an AFP prime and boost immunization strategy, more infiltrating CD8+ T cells appeared in the tumors, and AFP499 and AFP212 peptides significantly delayed the subcutaneous and DEN-induced mouse HCC development (13).